Beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

Schmidt Sigrun Alba Johannesdottir; Schmidt Morten

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

【24h】

Beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

机译：Beta受体阻滞剂和提高的卵巢癌生存率：新的奇迹疗法还是不朽的人际偏见案例？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2016年第2期|共2页
作者
Schmidt Sigrun Alba Johannesdottir; Schmidt Morten;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to beta blockers in epithelial ovarian cancer and beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias? [J] . Thaker Premal H., Urbauer Diana L., Sood Anil K. Cancer: A Journal of the American Cancer Society . 2016,第2期

机译：答复上皮性卵巢癌中的β受体阻滞剂和β受体阻滞剂并提高卵巢癌的生存率：新的奇迹疗法还是不朽的人际偏见案例？
2. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis [J] . Janick Weberpals, Lina Jansen, Myrthe P. P. van Herk-Sukel, European journal of epidemiology . 2017,第11期

机译：药物病毒血液学研究中的不朽时间偏见癌症患者存活的研究：β-障碍物的实证例子在四种癌症中使用不同预后
3. Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer (vol 14, pg 465, 2019) [J] . Wan Y. Louise, Sapra Puja, Bolton James, Targeted oncology . 2019,第6期

机译：用抗体 - 药物缀合物（A1MCMMAF）的组合处理靶向幼特糖蛋白5T4和卡铂改善卵巢癌的异种移植模型中的存活（Vol 14，PG 465,2019）
4. Plasmonic nanosensor in the treatment of cancer: An attempt to conquer the immortal illness [C] . Saikat Das, Jari Turunen EOS topical meeting on diffractive optics . 2012

机译：等离子纳米传感器在治疗癌症中：征服不朽疾病的尝试
5. Studies on the Survival of Ovarian Cancer Cells Following Treatment with Beta-Adrenergic Receptor Agonists and Antagonists [D] . Horan, Noah Patrick. 2020

机译：用β-肾上腺素能受体激动剂和拮抗剂治疗卵巢癌细胞存活的研究
6. Improved Survival of a Patient with Gastric and Other Multiple Metastases from Ovarian Cancer by Multimodal Treatment: A Case Report [O] . Seonmi Hwangbo, Oh Kyoung Kwon, Ho Young Chung, 2015

机译：多模式治疗改善卵巢癌胃癌及其他多发转移患者的生存率：一例报告
7. Reply to beta blockers in epithelial ovarian cancer and beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias? [O] . Premal H. Thaker, Diana L. Urbauer, Anil K. Sood 2015

机译：回复上皮细胞卵巢癌和β阻滞剂的β受体阻滞剂，并从卵巢癌中提高生存率：新的奇迹治疗或其他不朽人类时间偏见的情况？

Beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

著录项

相似文献

相关主题

期刊订阅